• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL0900430 注射用盐酸拓扑替康 topotecan hydrochloride Lyophilized Chemical Drugs Import Drug Application 2010-01-04 阿特维斯集团贸易有限公司 Actavis Group Certificate Issued 2016-07-25 view
X0304239 注射用盐酸拓扑替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2003-08-13 扬州奥赛康药业有限公司 Yangzhou Aosaikang Pharmaceutical Co Ltd Certificate Issued 2004-01-14 view
CXb01084 注射用盐酸拓扑替康 topotecan hydrochloride Lyophilized Chemical Drugs(2) Supplementary Application 2001-03-16 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd Pending Approval 2001-09-19 view
JYHB1701177 注射用盐酸拓扑替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2017-09-12 上海诺华贸易有限公司 Shanghai Novartis Trading Ltd Filed 2017-09-25 view
CYHS1100813 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs(6) Generic Drug 2011-11-10 山西普德药业股份有限公司 Shanxi PUDE Pharmaceutical Co Ltd Certificate Issued 2017-02-13 view
JYHB1801388 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2018-11-30 Certificate Issued 2019-01-18 view
JYHB0800826 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2009-02-06 SmithKline Beecham plc Smithkline Beecham Plc Certificate Issued 2009-10-12 view
JYHB1701055 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2017-08-04 上海诺华贸易有限公司 Shanghai Novartis Trading Ltd Filed 2017-08-30 view
JYHB2200571 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs(5.1) Supplementary Application 2022-10-24 view
H20020228 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Import Drug Application 2002-09-16 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2003-11-06 view
JYHB1800404 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2018-04-08 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Filed 2018-04-17 view
JYHZ0700201 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs License Renew 2007-10-22 SmithKline Beecham plc Smithkline Beecham Plc Certificate Issued 2008-08-12 view
JYHB1400604 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2014-05-12 Certificate Issued 2015-10-30 view
JYHZ2200229 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs License Renew 2022-08-18 view
JYHB1400404 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2014-05-06 Certificate Issued 2014-11-24 view
JYHB2000990 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2020-06-25 Filed 2020-06-29 view
CYHS0900630 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs(6) Generic Drug 2009-10-10 哈尔滨誉衡药业股份有限公司 Harbin Gloria Pharmaceuticals Co Ltd Certificate Issued 2011-12-13 view
JYHZ1700318 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs License Renew 2018-02-03 上海诺华贸易有限公司 Shanghai Novartis Trading Ltd Certificate Issued 2018-06-11 view
H20020285 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Import Drug Application 2002-11-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2003-08-15 view
JYHB2000199 注射用盐酸托泊替康 topotecan hydrochloride Lyophilized Chemical Drugs Supplementary Application 2020-03-05 Filed 2020-03-06 view